News
Today, the World Health Organization (WHO) published its first-ever position paper on immunization products to protect ...
The CDC reported the mistake involving two vaccines used to treat RSV, a serious respiratory virus. The vaccines were approved for distribution in May. Neither of the vaccines, Pfizer Abrysvo made ...
An estimated 15,000–20,000 annual RSV-associated hospitalizations occur in the U.S. in adults aged 50–59 years, according to the CDC. The panel was initially due to meet in February but the ...
CDC advisors voted to lower the age of RSV vaccination to include people as young as age 50. In the absence of a director, the recommendation will be sent to the CDC chief of staff for consideration.
Wastewater levels of RSV rose to "moderate" nationwide for the week ending Dec. 21, according to the CDC's wastewater monitoring system. That's the first time it has risen to that level since ...
If accepted by the CDC, the vote on the use of RSV vaccines in people in their 50s would initially apply to vaccines sold by GSK and Pfizer. Moderna is in the process of applying to the FDA to ...
As of Monday, Jan. 13, COVID-19 activity has increased in most areas in the U.S. while seasonal flu activity remains elevated across the country, the CDC said. Meanwhile, RSV activity is very high ...
Cases of RSV across the country are considered "very high," as rates of other acute respiratory illnesses are also high, the CDC reported Monday. Here's what to know about RSV. Iowa currently is ...
For RSV in particular, nearly two dozen states are currently reporting high levels, according to the U.S. Centers for Disease Control and Prevention (CDC)'s wastewater monitoring system.
RSV, and the flu, the CDC says. Fmr. DoD official explains why the Signal group chat was classified the moment it was created Protestors Stage Elon Musk Posters On Tesla Charging Stations In ...
N.C. included, 18 states and the District of Columbia have "high" or "very high" levels of RSV in their wastewater according to CDC data. Additionally, seven states have "moderate" levels ...
Studies presented to the CDC’s Advisory Committee on Immunization Practices Work Group for RSV found a 78.7% efficacy of a single dose “preventing symptomatic, laboratory-confirmed (RSV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results